![Marie Yurkovich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marie Yurkovich
Operationeel Directeur bij Oak Hill Bio Corp.
Actieve functies van Marie Yurkovich
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Operationeel Directeur | - | - |
Loopbaan van Marie Yurkovich
Eerdere bekende functies van Marie Yurkovich
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Vectr Ventures Ltd
![]() Vectr Ventures Ltd Investment ManagersFinance Vectr Ventures Ltd is a venture capital firm founded in 2009 by Arthur Law, Alan Chan, Jason Best, Mark Munoz and Adrian Chan. The firm is headquartered in Hong Kong. | Private Equity Analist | 01-02-2019 | 01-02-2020 |
Statistieken
Internationaal
Hongkong | 2 |
Verenigd Koninkrijk | 2 |
Operationeel
Private Equity Analyst | 1 |
Chief Operating Officer | 1 |
Sectoraal
Finance | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Vectr Ventures Ltd
![]() Vectr Ventures Ltd Investment ManagersFinance Vectr Ventures Ltd is a venture capital firm founded in 2009 by Arthur Law, Alan Chan, Jason Best, Mark Munoz and Adrian Chan. The firm is headquartered in Hong Kong. | Finance |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
- Beurs
- Insiders
- Marie Yurkovich
- Ervaring